Tuesday, April 18, 2023 3:54:10 PM
Can anyone explain why they are still referring to the new case # 6:22-cv-00356 ? The original is 6:20-cv-00666. It says JA is taking it under advisement. Shouldn’t JA have ruled on this before setting the schedule ? THX
_________________________________
GS...no doubt everyone has noticed that and even JA far more than all of us however, for JA to act in a neutral manner he probably needs to be cautious on how to introduce that aspect. I sincerely feel he has already made up his mind to allow HDC to use all evidence dating back to the 6:20-vc-00666 case history especially when considering how JA is using and considering the remaining Fact Discovery time. The case number may remain 6:22-cv--00356 and we should not be concerned as long as we get to use all the past documentations from the original court case and the two plus years of possible liability award.
As I see things investors here may feel that Intel has the upper hand with all this stalling but I tend to differ meaning HDC has also had additional time to work on any weak areas they may see within themselves and also Intel's block walls that are looking weaker as time move along.
Another thingy about the PATB having that final say prior. Yes I doubt the USPTO will have much to say simply because Intel (in my words/thoughts) are done with the USPTO and it is onward to the U.S. Appeals Court which is about the USPTO structure.
Judge Albright will carry the football and body block everyone expect the U.S Appeals Court as they stand taller than JA or the USPTO Director.
Something I don't think anyone here (so far) has thought about, what is going to transpire in recognition and Publicity for the Attorney's and Firm of the winning team
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 07:53:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM